<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9343406" created="17/11/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9343406</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Blockade of <term id="T1" lex="T-cell_activation" sem="Other"><term id="A1" sem="Cell_natural">T-cell</term> activation</term> by <term id="T2" lex="dithiocarbamate" sem="Organic_compound_other">dithiocarbamates</term> involves novel mechanisms of inhibition of <term id="T3" lex="nuclear_factor_of_activated_T_cells" sem="Protein_family_or_group">nuclear factor of activated T cells</term>.</sentence>
<event KT="Other" id="E1">
<type class="Physiological_process"/>
<theme idref="A1"/>
<clue>Blockade of T-cell <clueType>activation</clueType> by dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.</clue>
</event>
<event id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<cause idref="T2"/>
<clue><clueType>Blockade</clueType> <linkTheme>of</linkTheme> T-cell activation <linkCause>by</linkCause> dithiocarbamates involves novel mechanisms of inhibition of nuclear factor of activated T cells.</clue>
</event>
<event id="E3">
<type class="Negative_regulation"/>
<theme idref="T3"/>
<clue>Blockade of T-cell activation by dithiocarbamates involves novel mechanisms of <clueType>inhibition</clueType> <linkTheme>of</linkTheme> nuclear factor of activated T cells.</clue>
</event>
<event id="E4">
<type class="Correlation"/>
<theme idref="E2"/>
<theme idref="E3"/>
<clue>Blockade of T-cell activation by dithiocarbamates <clueType>involves</clueType> novel mechanisms of inhibition of nuclear factor of activated T cells.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T4" lex="dithiocarbamate" sem="Organic_compound_other">Dithiocarbamates</term> (<term id="T5" lex="DTC" sem="Organic_compound_other">DTCs</term>) have recently been reported as powerful inhibitors of <term id="T6" lex="NF-kappaB_activation" sem="Other"><term id="T7" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> in a number of cell types.</sentence>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<clue>Dithiocarbamates (DTCs) have recently been reported as powerful inhibitors of NF-kappaB <clueType>activation</clueType> in a number of cell types.</clue>
</event>
<event KT="Analysis" Manner="High" Source="Other" id="E6">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<cause idref="T5"/>
<clue>Dithiocarbamates (DTCs) have <clueSource>recently</clueSource> been <clueKT>reported</clueKT> as <clueManner>powerful</clueManner> <clueType>inhibitors</clueType> <linkTheme>of</linkTheme> NF-kappaB activation <clueLoc>in a number of cell types</clueLoc>.</clue>
</event>
<sentence id="S3">Given the role of this transcription factor in the regulation of <term id="T8" lex="gene_expression" sem="Other">gene expression</term> in the <term id="T9" lex="inflammatory_response" sem="Other">inflammatory response</term>, <term id="T10" lex="NF-kappaB_inhibitor" sem="Organic_compound_other"><term id="T11" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> inhibitors</term> have been suggested as potential <term id="T12" lex="therapeutic_drug" sem="Organic_compound_other">therapeutic drugs</term> for <term id="T13" lex="inflammatory_disease" sem="Other">inflammatory diseases</term>.</sentence>
<event KT="Other" id="E7">
<type class="Regulation"/>
<theme idref="T8"/>
<clue>Given the role of this transcription factor in the <clueType>regulation</clueType> <linkTheme>of</linkTheme> gene expression <clueTime>in the inflammatory response</clueTime>, NF-kappaB inhibitors have been suggested as potential therapeutic drugs for inflammatory diseases.</clue>
</event>
<event KT="Fact" id="E8">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="T7"/>
<clue>Given the <clueType>role</clueType> <linkCause>of</linkCause> <corefCause>this transcription factor</corefCause> <linkTheme>in</linkTheme> the regulation of gene expression in the inflammatory response, NF-kappaB inhibitors have been suggested as potential therapeutic drugs for inflammatory diseases.</clue>
</event>
<event KT="Other" id="E9">
<type class="Negative_regulation"/>
<theme idref="T11"/>
<clue>Given the role of this transcription factor in the regulation of gene expression in the inflammatory response, NF-kappaB <clueType>inhibitors</clueType> have been suggested as potential therapeutic drugs for inflammatory diseases.</clue>
</event>
<sentence id="S4">We show here that <term id="T14" lex="DTC" sem="Organic_compound_other">DTCs</term> inhibited both <term id="T15" lex="interleukin_2_(IL-2)_synthesis" sem="Other"><term id="T16" lex="interleukin_2" sem="Protein_molecule">interleukin 2</term> (<term id="T17" lex="IL-2" sem="Protein_molecule">IL-2</term>) synthesis</term> and membrane expression of <term id="T18" lex="antigen" sem="Protein_family_or_group">antigens</term> which are induced during <term id="T19" lex="T-cell_activation" sem="Other"><term id="A2" sem="Cell_natural">T-cell</term> activation</term>.</sentence>
<event KT="Other" id="E10">
<type class="Gene_expression"/>
<theme idref="T17"/>
<clue>We show here that DTCs inhibited both interleukin 2 (IL-2) <clueType>synthesis</clueType> and membrane expression of antigens which are induced during T-cell activation.</clue>
</event>
<event KT="Other" id="E11">
<type class="Gene_expression"/>
<theme idref="T18"/>
<clue>We show here that DTCs inhibited both interleukin 2 (IL-2) synthesis and <clueLoc>membrane</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> antigens which are induced during T-cell activation.</clue>
<comment>ERROR &quot;THEME is not T19 but T18&quot;</comment></event>
<event KT="Other" id="E12">
<type class="Positive_regulation"/>
<theme idref="T19"/>
<clue>We show here that DTCs inhibited both interleukin 2 (IL-2) synthesis and membrane expression of antigens which are <clueType>induced</clueType> <clueTime>during T-cell activation</clueTime>.</clue>
</event>
<event KT="Analysis" id="E13">
<type class="Negative_regulation"/>
<theme idref="E10"/>
<cause idref="T14"/>
<clue>We <clueKT>show</clueKT> here that DTCs <clueType>inhibited</clueType> both interleukin 2 (IL-2) synthesis and membrane expression of antigens which are induced during T-cell activation.</clue>
</event>
<event KT="Analysis" id="E14">
<type class="Negative_regulation"/>
<theme idref="E11"/>
<cause idref="T14"/>
<clue>We <clueKT>show</clueKT> here that DTCs <clueType>inhibited</clueType> both interleukin 2 (IL-2) synthesis and membrane expression of antigens which are induced during T-cell activation.</clue>
</event>
<event KT="Other" id="E15">
<type class="Physiological_process"/>
<theme idref="A2"/>
<clue>We show here that DTCs inhibited both interleukin 2 (IL-2) synthesis and membrane expression of antigens which are induced during T-cell <clueType>activation</clueType>.</clue>
</event>
<sentence id="S5">This inhibition, which occurred with a parallel activation of <term id="T20" lex="c-Jun_transactivating_function" sem="Other"><term id="T21" lex="c-Jun" sem="Protein_molecule">c-Jun</term> transactivating functions</term> and expression, was reflected by <term id="T22" lex="transfection_experiment" sem="Other">transfection experiments</term> at the <term id="T23" lex="IL-2_promoter_level" sem="Other"><term id="T24" lex="IL-2_promoter" sem="DNA_domain_or_region"><term id="T25" lex="IL-2" sem="Protein_molecule">IL-2</term> promoter</term> level</term>, and involved not only the inhibition of <term id="T26" lex="NF-kappaB-driven_reporter_activation" sem="Other"><term id="T27" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>-driven <term id="A3" sem="DNA_domain_or_region">reporter</term> activation</term> but also that of <term id="T28" lex="nuclear_factor_of_activated_T_cells" sem="Protein_family_or_group">nuclear factor of activated T cells</term> (<term id="T29" lex="NFAT" sem="Protein_family_or_group">NFAT</term>).</sentence>
<event id="E16">
<type class="Positive_regulation"/>
<cause idref="T21"/>
<clue>This inhibition, which occurred with a parallel activation of c-Jun <clueType>transactivating functions</clueType> and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E17">
<type class="Gene_expression"/>
<theme idref="T21"/>
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and <clueType>expression</clueType>, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<clue>This inhibition, which occurred with a parallel <clueType>activation</clueType> <linkTheme>of</linkTheme> c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<clue>This inhibition, which occurred with a parallel <clueType>activation</clueType> <linkTheme>of</linkTheme> c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E20">
<type class="Correlation"/>
<theme idref="E13"/>
<theme idref="E18"/>
<clue><corefTheme>This inhibition</corefTheme>, which <clueType>occurred</clueType> <linkTheme>with</linkTheme> a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E21">
<type class="Correlation"/>
<theme idref="E13"/>
<theme idref="E19"/>
<clue><corefTheme>This inhibition</corefTheme>, which <clueType>occurred</clueType> <linkTheme>with</linkTheme> a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E22">
<type class="Correlation"/>
<theme idref="E14"/>
<theme idref="E18"/>
<clue><corefTheme>This inhibition</corefTheme>, which <clueType>occurred</clueType> <linkTheme>with</linkTheme> a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E23">
<type class="Correlation"/>
<theme idref="E14"/>
<theme idref="E19"/>
<clue><corefTheme>This inhibition</corefTheme>, which <clueType>occurred</clueType> <linkTheme>with</linkTheme> a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event KT="Other" id="E24">
<type class="Positive_regulation"/>
<theme idref="A3"/>
<cause idref="T27"/>
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-<linkCause>driven</linkCause> reporter <clueType>activation</clueType> but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E25">
<type class="Negative_regulation"/>
<theme idref="E24"/>
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the <clueType>inhibition</clueType> <linkTheme>of</linkTheme> NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E26">
<type class="Negative_regulation"/>
<theme idref="T29"/>
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and involved not only the inhibition of NF-kappaB-driven reporter activation but also <clueType>that</clueType> <linkTheme>of</linkTheme> nuclear factor of activated T cells (NFAT).</clue>
<comment>CAUTION: that=inhibition</comment></event>
<event id="E27">
<type class="Correlation"/>
<theme idref="E13"/>
<theme idref="E25"/>
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and <clueType>involved</clueType> not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E28">
<type class="Correlation"/>
<theme idref="E13"/>
<theme idref="E26"/>
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and <clueType>involved</clueType> not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E29">
<type class="Correlation"/>
<theme idref="E14"/>
<theme idref="E25"/>
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and <clueType>involved</clueType> not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<event id="E30">
<type class="Correlation"/>
<theme idref="E14"/>
<theme idref="E26"/>
<clue>This inhibition, which occurred with a parallel activation of c-Jun transactivating functions and expression, was reflected by transfection experiments at the IL-2 promoter level, and <clueType>involved</clueType> not only the inhibition of NF-kappaB-driven reporter activation but also that of nuclear factor of activated T cells (NFAT).</clue>
</event>
<sentence id="S6">Accordingly, <term id="T30" lex="electrophoretic_mobility_shift_assay" sem="Other">electrophoretic mobility shift assays</term> (<term id="T31" lex="EMSA" sem="Other">EMSAs</term>) indicated that <term id="T32" lex="pyrrolidine_DTC" sem="Organic_compound_other">pyrrolidine DTC</term> (<term id="T33" lex="PDTC" sem="Organic_compound_other">PDTC</term>) prevented <term id="T34" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>, and <term id="T35" lex="NFAT_DNA-binding_activity" sem="Other"><term id="T36" lex="NFAT" sem="Protein_family_or_group">NFAT</term> <term id="A4" sem="DNA_domain_or_region">DNA</term>-binding activity</term> in <term id="T37" lex="T_cell" sem="Cell_natural">T cells</term> stimulated with either <term id="T38" lex="phorbol_myristate_acetate" sem="Organic_compound_other">phorbol myristate acetate</term> plus <term id="T39" lex="ionophore" sem="Organic_compound_other">ionophore</term> or <term id="A16" sem="Protein_family_or_group">antibodies against the <term id="T40" lex="CD3-T-cell_receptor_complex" sem="Protein_complex">CD3-T-cell receptor complex</term></term> and simultaneously activated the binding of <term id="T41" lex="AP-1" sem="Protein_molecule">AP-1</term>.</sentence>
<event KT="Other" id="E31">
<type class="Binding"/>
<theme idref="T34"/>
<theme idref="A4"/>
<clue>Accordingly, electrophoretic mobility shift assays (EMSAs) indicated that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-<clueType>binding activity</clueType> in T cells stimulated with either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
</event>
<event KT="Other" id="E32">
<type class="Binding"/>
<theme idref="T36"/>
<theme idref="A4"/>
<clue>Accordingly, electrophoretic mobility shift assays (EMSAs) indicated that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-<clueType>binding activity</clueType> in T cells stimulated with either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
</event>
<event CL="L2" KT="Analysis" id="E33">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T33"/>
<clue>Accordingly, <clueExperiment>electrophoretic mobility shift assays (EMSAs)</clueExperiment> <clueKT><clueCL>indicated</clueCL></clueKT> that pyrrolidine DTC (PDTC) <clueType>prevented</clueType> NF-kappaB, and NFAT DNA-binding activity <clueLoc>in T cells stimulated with either phorbol myristate acetate plus ionophore</clueLoc> or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
</event>
<event CL="L2" KT="Analysis" id="E133">
<type class="Negative_regulation"/>
<theme idref="E31"/>
<cause idref="T33"/>
<clue>Accordingly, <clueExperiment>electrophoretic mobility shift assays (EMSAs)</clueExperiment> <clueKT><clueCL>indicated</clueCL></clueKT> that pyrrolidine DTC (PDTC) <clueType>prevented</clueType> NF-kappaB, and NFAT DNA-binding activity i<clueLoc>n T cells stimulated with</clueLoc> either phorbol myristate acetate plus ionophore or <clueLoc>antibodies against the CD3-T-cell receptor complex</clueLoc> and simultaneously activated the binding of AP-1.</clue>
</event>
<event CL="L2" KT="Analysis" id="E34">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T33"/>
<clue>Accordingly, <clueExperiment>electrophoretic mobility shift assays (EMSAs)</clueExperiment> <clueKT><clueCL>indicated</clueCL></clueKT> that pyrrolidine DTC (PDTC) <clueType>prevented</clueType> NF-kappaB, and NFAT DNA-binding activity <clueLoc>in T cells stimulated with either phorbol myristate acetate plus ionophore</clueLoc> or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
</event>
<event CL="L2" KT="Analysis" id="E134">
<type class="Negative_regulation"/>
<theme idref="E32"/>
<cause idref="T33"/>
<clue>Accordingly, <clueExperiment>electrophoretic mobility shift assays (EMSAs)</clueExperiment> <clueKT><clueCL>indicated</clueCL></clueKT> that pyrrolidine DTC (PDTC) <clueType>prevented</clueType> NF-kappaB, and NFAT DNA-binding activity <clueLoc>in T cells stimulated with</clueLoc> either phorbol myristate acetate plus ionophore or <clueLoc>antibodies against the CD3-T-cell receptor complex</clueLoc> and simultaneously activated the binding of AP-1.</clue>
</event>
<event KT="Other" id="E35">
<type class="Physiological_process"/>
<theme idref="T37"/>
<cause idref="T38"/>
<cause idref="T39"/>
<clue>Accordingly, electrophoretic mobility shift assays (EMSAs) indicated that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-binding activity in T cells <clueType>stimulated</clueType> <linkCause>with</linkCause> either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
</event>
<event KT="Other" id="E36">
<type class="Physiological_process"/>
<theme idref="T37"/>
<cause idref="A16"/>
<clue>Accordingly, electrophoretic mobility shift assays (EMSAs) indicated that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-binding activity in T cells <clueType>stimulated</clueType> <linkCause>with</linkCause> either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously activated the binding of AP-1.</clue>
<comment>TPS A16</comment></event>
<event KT="Other" id="E37">
<type class="Binding"/>
<theme idref="T41"/>
<theme idref="A4"/>
<clue>Accordingly, electrophoretic mobility shift assays (EMSAs) indicated that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-binding activity in T cells stimulated with either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously activated the <clueType>binding</clueType> <linkTheme>of</linkTheme> AP-1.</clue>
</event>
<event CL="L2" KT="Analysis" id="E38">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T33"/>
<clue>Accordingly, <clueExperiment>electrophoretic mobility shift assays (EMSAs)</clueExperiment> <clueKT><clueCL>indicated</clueCL></clueKT> that pyrrolidine DTC (PDTC) prevented NF-kappaB, and NFAT DNA-binding activity in T cells stimulated with either phorbol myristate acetate plus ionophore or antibodies against the CD3-T-cell receptor complex and simultaneously <clueType>activated</clueType> the binding of AP-1.</clue>
</event>
<sentence id="S7">Furthermore, <term id="T42" lex="PDTC" sem="Organic_compound_other">PDTC</term> differentially targeted both <cons id="T43" lex="(AND NFATp_family_member NFATc_family_member)" sem="(AND Protein_family_or_group Protein_family_or_group)"><frag id="F1"><term id="A6" sem="Protein_family_or_group">NFATp</term></frag> and <frag id="F2"><term id="A7" sem="Protein_family_or_group">NFATc</term></frag> <frag id="F3"><term id="A8" sem="Protein_family_or_group">family members</term></frag></cons>, inhibiting the transactivation functions of <term id="T44" lex="NFATp" sem="Protein_family_or_group">NFATp</term> and <term id="T45" lex="mRNA_induction" sem="Other">mRNA induction</term> of <term id="T46" lex="NFATc" sem="Protein_family_or_group">NFATc</term>.</sentence>
<event id="E39">
<type class="Regulation"/>
<theme idref="A6" idref1="A8"/>
<cause idref="T42"/>
<clue>Furthermore, PDTC differentially <clueType>targeted</clueType> both NFATp and NFATc family members, inhibiting the transactivation functions of NFATp and mRNA induction of NFATc.</clue>
</event>
<event id="E40">
<type class="Regulation"/>
<theme idref="A7" idref1="A8"/>
<cause idref="T42"/>
<clue>Furthermore, PDTC differentially <clueType>targeted</clueType> both NFATp and NFATc family members, inhibiting the transactivation functions of NFATp and mRNA induction of NFATc.</clue>
</event>
<event KT="Other" id="E41">
<type class="Positive_regulation"/>
<cause idref="T44"/>
<clue>Furthermore, PDTC differentially targeted both NFATp and NFATc family members, inhibiting the <clueType>transactivation functions</clueType> <linkCause>of</linkCause> NFATp and mRNA induction of NFATc.</clue>
</event>
<event KT="Other" id="E141">
<type class="Transcription"/>
<theme idref="T46"/>
<clue>Furthermore, PDTC differentially targeted both NFATp and NFATc family members, inhibiting the transactivation functions of NFATp and <clueType>mRNA induction</clueType> <linkTheme>of</linkTheme> NFATc.</clue>
</event>
<event id="E42">
<type class="Negative_regulation"/>
<theme idref="E40"/>
<cause idref="T42"/>
<clue>Furthermore, PDTC differentially targeted both NFATp and NFATc family members, <clueType>inhibiting</clueType> the transactivation functions of NFATp and mRNA induction of NFATc.</clue>
</event>
<event id="E43">
<type class="Negative_regulation"/>
<theme idref="E141"/>
<cause idref="T42"/>
<clue>Furthermore, PDTC differentially targeted both NFATp and NFATc family members, <clueType>inhibiting</clueType> the transactivation functions of NFATp and mRNA induction of NFATc.</clue>
</event>
<sentence id="S8">Strikingly, <term id="T47" lex="Western_blotting" sem="Other">Western blotting</term> and <term id="T48" lex="immunocytochemical_experiment" sem="Other">immunocytochemical experiments</term> indicated that <term id="T49" lex="PDTC" sem="Organic_compound_other">PDTC</term> promoted a transient and rapid shuttling of <term id="T50" lex="NFATp" sem="Protein_family_or_group">NFATp</term> and <term id="T51" lex="NFATc" sem="Protein_family_or_group">NFATc</term>, leading to their accelerated export from the <term id="T52" lex="nucleus" sem="Cell_component">nucleus</term> of <term id="T53" lex="activated_T_cell" sem="Cell_natural">activated <term id="T54" lex="T_cell" sem="Cell_natural">T cells</term></term>.</sentence>
<event KT="Other" Manner="High" id="E44">
<type class="Localization"/>
<theme idref="T50"/>
<clue>Strikingly, Western blotting and immunocytochemical experiments indicated that PDTC promoted a transient and <clueManner>rapid</clueManner> <clueType>shuttling</clueType> <linkTheme>of</linkTheme> NFATp and NFATc, leading to their accelerated export from the nucleus of activated T cells.</clue>
</event>
<event KT="Other" Manner="High" id="E45">
<type class="Localization"/>
<theme idref="T51"/>
<clue>Strikingly, Western blotting and immunocytochemical experiments indicated that PDTC promoted a transient and <clueManner>rapid</clueManner> <clueType>shuttling</clueType> <linkTheme>of</linkTheme> NFATp and NFATc, leading to their accelerated export from the nucleus of activated T cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E46">
<type class="Positive_regulation"/>
<theme idref="E44"/>
<cause idref="T49"/>
<clue>Strikingly, Western blotting and immunocytochemical experiments <clueKT><clueCL>indicated</clueCL></clueKT> that PDTC <clueType>promoted</clueType> a transient and rapid shuttling of NFATp and NFATc, leading to their accelerated export from the nucleus of activated T cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E47">
<type class="Positive_regulation"/>
<theme idref="E45"/>
<cause idref="T49"/>
<clue>Strikingly, Western blotting and immunocytochemical experiments <clueKT><clueCL>indicated</clueCL></clueKT> that PDTC <clueType>promoted</clueType> a transient and rapid shuttling of NFATp and NFATc, leading to their accelerated export from the nucleus of activated T cells.</clue>
</event>
<event KT="Other" Manner="High" id="E48">
<type class="Localization"/>
<theme idref="T50"/>
<clue>Strikingly, Western blotting and immunocytochemical experiments indicated that PDTC promoted a transient and rapid shuttling of NFATp and NFATc, leading to <corefTheme>their</corefTheme> <clueManner>accelerated</clueManner> <clueType>export</clueType> <clueLoc>from the nucleus of activated T cells</clueLoc>.</clue>
</event>
<event KT="Other" Manner="High" id="E49">
<type class="Localization"/>
<theme idref="T51"/>
<clue>Strikingly, Western blotting and immunocytochemical experiments indicated that PDTC promoted a transient and rapid shuttling of NFATp and NFATc, leading to <corefTheme>their</corefTheme> <clueManner>accelerated</clueManner> <clueType>export</clueType> <clueLoc>from the nucleus of activated T cells</clueLoc>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E50">
<type class="Positive_regulation"/>
<theme idref="E48"/>
<cause idref="E46"/>
<clue>Strikingly, <clueExperiment>Western blotting and immunocytochemical experiments</clueExperiment> <clueKT><clueCL>indicated</clueCL></clueKT> that PDTC promoted a transient and rapid shuttling of NFATp and NFATc, <clueType>leading to their accelerated</clueType> export from the nucleus of activated T cells.</clue>
</event>
<event CL="L2" KT="Analysis" id="E51">
<type class="Positive_regulation"/>
<theme idref="E49"/>
<cause idref="E47"/>
<clue>Strikingly, <clueExperiment>Western blotting and immunocytochemical experiments</clueExperiment> <clueKT><clueCL>indicated</clueCL></clueKT> that PDTC promoted a transient and rapid shuttling of NFATp and NFATc, <clueType>leading to their accelerated</clueType> export from the nucleus of activated T cells.</clue>
</event>
<sentence id="S9">We propose that the activation of an <term id="A5" sem="Protein_molecule">NFAT kinase</term> by <term id="T55" lex="PDTC" sem="Organic_compound_other">PDTC</term> could be responsible for the rapid shuttling of the <term id="T56" lex="NFAT" sem="Protein_family_or_group">NFAT</term>, therefore transiently converting the sustained transactivation of this <term id="T57" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> that occurs during <term id="T58" lex="lymphocyte_activation" sem="Other"><term id="A9" sem="Cell_natural">lymphocyte</term> activation</term>, and show that <term id="T59" lex="c-Jun_NH2-terminal_kinase" sem="Protein_molecule">c-Jun NH2-terminal kinase</term> (<term id="T60" lex="JNK" sem="Protein_molecule">JNK</term>) can act by directly phosphorylating <term id="T61" lex="NFATp" sem="Protein_family_or_group">NFATp</term>.</sentence>
<event KT="Other" id="E52">
<type class="Positive_regulation"/>
<theme idref="A5"/>
<cause idref="T55"/>
<clue>We propose that the <clueType>activation</clueType> <linkTheme>of</linkTheme> an NFAT kinase <linkCause>by</linkCause> PDTC could be responsible for the rapid shuttling of the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event KT="Other" Manner="High" id="E53">
<type class="Localization"/>
<theme idref="T56"/>
<clue>We propose that the activation of an NFAT kinase by PDTC could be responsible for the <clueManner>rapid</clueManner> <clueType>shuttling</clueType> <linkTheme>of</linkTheme> the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event CL="L1" KT="Analysis" id="E54">
<type class="Positive_regulation"/>
<theme idref="E53"/>
<cause idref="E52"/>
<clue>We <clueKT>propose</clueKT> that the activation of an NFAT kinase by PDTC <clueCL>could</clueCL> be <clueType>responsible</clueType> <linkTheme>for</linkTheme> the rapid shuttling of the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event KT="Other" id="E55">
<type class="Positive_regulation"/>
<theme idref="T56"/>
<cause idref="T56"/>
<clue>We propose that the activation of an NFAT kinase by PDTC could be responsible for the rapid shuttling of the NFAT, therefore transiently converting the sustained <clueType>transactivation</clueType> <linkTheme>of</linkTheme> <corefTheme>this transcription factor</corefTheme> that occurs <clueTime>during lymphocyte activation</clueTime>, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event CL="L1" KT="Analysis" id="E56">
<type class="Positive_regulation"/>
<theme idref="E55"/>
<cause idref="E54"/>
<clue>We <clueKT>propose</clueKT> that the activation of an NFAT kinase by PDTC <clueCL>could</clueCL> be <clueType>responsible</clueType> <linkTheme>for</linkTheme> the rapid shuttling of the NFAT, <linkCause><clueKT>therefore</clueKT></linkCause> transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event KT="Other" id="E57">
<type class="Physiological_process"/>
<theme idref="A9"/>
<clue>We propose that the activation of an NFAT kinase by PDTC could be responsible for the rapid shuttling of the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte <clueType>activation</clueType>, and show that c-Jun NH2-terminal kinase (JNK) can act by directly phosphorylating NFATp.</clue>
</event>
<event CL="L2" KT="Analysis" id="E58">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T61"/>
<cause idref="T60"/>
<clue>We propose that the activation of an NFAT kinase by PDTC could be responsible for the rapid shuttling of the NFAT, therefore transiently converting the sustained transactivation of this transcription factor that occurs during lymphocyte activation, and <clueKT>show</clueKT> that c-Jun NH2-terminal kinase (JNK) <clueCL>can</clueCL> <clueType>act by directly phosphorylating</clueType> NFATp.</clue>
</event>
<sentence id="S10">In addition, the combined inhibitory effects on <term id="T62" lex="NFAT" sem="Protein_family_or_group">NFAT</term> and <term id="T63" lex="NF-KB" sem="Protein_complex">NF-KB</term> support a potential use of <term id="T64" lex="DTC" sem="Organic_compound_other">DTCs</term> as immunosuppressants.</sentence>
<event id="E59">
<type class="Negative_regulation"/>
<theme idref="T62"/>
<cause idref="T64"/>
<clue>In addition, <corefCause>the</corefCause> combined <clueType>inhibitory effects</clueType> <linkTheme>on</linkTheme> NFAT and NF-KB support a potential use of DTCs as immunosuppressants.</clue>
</event>
<event id="E60">
<type class="Negative_regulation"/>
<theme idref="T63"/>
<cause idref="T64"/>
<clue>In addition, <corefCause>the</corefCause> combined <clueType>inhibitory effects</clueType> <linkTheme>on</linkTheme> NFAT and NF-KB support a potential use of DTCs as immunosuppressants.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
